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Background: There is an increasing proportion of elderly patients with peripheral artery disease. There are few papers on endovascular therapy for 
elderly patients with aorto-iliac lesions, and therefore we examined outcomes for patients 80 years or older in this setting.
Methods: We retrospectively analyzed a prospectively maintained multicenter database. Subjects included a consecutive series (January 2005 and 
December 2009) of patients who underwent stenting for aorto-iliac lesions. Primary endpoint was rate of primary and secondary patency. Secondary 
endpoints were rates of target lesion re-intervention and major adverse limb events (MALE) that include all-cause death, myocardial infarction, 
stroke, major amputation and any re-intervention. Outcomes were compared to those of patients aged under 80 years old.
Results: A total of 2096 patients (2601 lesions, mean age: 71.3±7.5 years) were analyzed. The mean follow-up interval was 31.2 ±15.0 months. 
403 patients (501 lesions) were 80 years and older. Primary and secondary patency was not significantly different between patients 80 years or 
older and those under 80 years old (p=0.39 and 0.4, respectively). Similarly, rates of target lesion re-intervention were not significantly different 
(p=0.4) however MALE rate was significantly higher compared to that for patients under 80 years old (p=0.003).
Conclusions: Endovascular therapy for aorto-iliac lesions is worthwhile in elderly patients. 
